2025

>

Metabolic dysfunction associated steatotic liver disease: the new mapping of a silent disease

>

Importance of the new steatotic liver disease nomenclature

>

Epidemiology of metabolic hepatic steatosis

>

Pathophysiology of metabolic dysfunction associated steatotic liver disease

>

Endocrine aspects beyond insulin resistance in metabolic dysfunction associated steatotic liver disease

>

Metabolic comorbidity in metabolic dysfunction associated steatotic liver disease

>

Cardiovascular risk in metabolic dysfunction associated steatotic liver disease

>

Initial evaluation of the patient with metabolic dysfunction–associated steatotic liver disease

>

Alcohol and metabolic dysfunction interaction: MetALD

>

Metabolic hepatic steatosis and hepatocellular carcinoma